CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $347,711,405
- in 75 filings, $346.9M under 10b5-1 plans
Net −$347,711,405. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-20 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −500 | $578.90 | $289K | 22,416 |
| 2026-04-20 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −340 | $579.86 | $197K | 22,076 |
| 2026-04-20 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −488 | $581.66 | $284K | 21,588 |
| 2026-04-20 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −983 | $582.47 | $573K | 20,605 |
| 2026-04-20 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,009 | $583.55 | $589K | 19,596 |
| 2026-04-20 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −482 | $584.49 | $282K | 19,114 |
| 2026-04-20 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −238 | $585.36 | $139K | 18,876 |
| 2026-04-20 | EDGEMOND JAMES CFO AND TREASURER | Option exercise · Stock Option 10b5-1 | −10,000 | 72,500 | ||
| 2026-04-20 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 50,013 |
| 2026-04-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −977 | $572.41 | $559K | 49,036 |
| 2026-04-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,683 | $573.57 | $965K | 47,353 |
| 2026-04-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −570 | $575.07 | $328K | 46,783 |
| 2026-04-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,179 | $575.96 | $679K | 45,604 |
| 2026-04-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,148 | $576.87 | $662K | 44,456 |
| 2026-04-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −165 | $577.94 | $95K | 44,291 |
| 2026-04-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −461 | $579.09 | $267K | 43,830 |
| 2026-04-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −277 | $579.92 | $161K | 43,553 |
| 2026-04-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −410 | $581.71 | $239K | 43,143 |
| 2026-04-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,070 | $582.46 | $623K | 42,073 |
| 2026-04-20 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −848 | $583.41 | $495K | 41,225 |
Page 120 of 121 · 2,404 trades